Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Marfan Syndrome

para>Careful monitoring, as described. Early surgical intervention may reduce the degree of scoliosis. ‚  
Pregnancy Considerations

  • Manage pregnancy in MFS as high risk, with a cardiologist; prepregnancy evaluation: screening transthoracic echocardiogram for aortic root dilation

  • Consider Ž ²-blockers in all pregnancies to minimize risk of aortic dilation throughout the pregnancy.

  • 1% complication rate if aortic root diameter <40 mm; 10% if >40 mm. Consider elective surgery before pregnancy if >47 mm.

  • Avoid spinal anesthesia due to risk of dural ectasia.

‚  

EPIDEMIOLOGY


  • Congenital; although clinical manifestations may be apparent in infancy, affected individuals may not present until adolescence or young adulthood.
  • No gender, ethnic, or racial predilection; with advanced paternal age, a slightly increased risk of de novo mutation resulting in MFS in offspring

Prevalence
1/5,000 to 1/10,000 ‚  

ETIOLOGY AND PATHOPHYSIOLOGY


Genetic abnormality; mutations of the FBN1 (fibrillin) gene. Fibrillin is an extracellular matrix protein widely distributed in elastic and nonelastic connective tissue. ‚  
Genetics
  • Mutations of the fibrillin-1 (FBN1) gene on chromosome 15q21.1 OMIM 154700.
  • MFS is an autosomal dominant condition with complete penetrance and variable expressivity. Apparent nonpenetrance may be due to lack of recognition of MFS in a mildly affected individual.
  • Each child of an affected parent has a 50% chance of inheriting MFS and may be more or less severely affected. 25% of cases result from de novo mutation.

GENERAL PREVENTION


Prenatal diagnosis is possible in families with a known mutation. ‚  

COMMONLY ASSOCIATED CONDITIONS


  • High prevalence of obstructive sleep apnea in MFS; may be a risk factor for aortic root dilatation
  • Increased prevalence of migraine in MFS

DIAGNOSIS


  • In the revised Ghent nosology:
    • Cardiovascular manifestations (aortic root aneurysm/dissection) and ectopia lentis have more weight.
    • Molecular genetic testing for FBN1 plays a more prominent diagnostic role but is not required.
    • Less specific manifestations were removed or made less influential, thus avoiding obligate thresholds that were not evidence based. Careful follow-up diminishes risk of missed diagnosis.
    • New criteria explicitly allow for alternative diagnoses, when additional features warrant: Shprintzen-Goldberg syndrome (SGS), Loeys-Dietz syndrome (LDS), or vascular-type Ehlers-Danlos syndrome (vEDS).
    • Z-score calculator for aortic root enlargement: http://www.marfan.org/
  • In the absence of a family history of MFS:
    • Aortic root dilatation or dissection (Z ≥2) (Ao) and ectopia lentis (EL): unequivocal diagnosis of MFS, irrespective of systemic features, except when they are diagnostic of SGS, LDS, or vEDS
    • Ao and a bona fide FBN1 mutation: diagnostic of MFS, even in the absence of EL
    • Where Ao is present but EL is absent and the FBN1 status is negative (or unknown), diagnosis of MFS requires systemic findings score of ≥7 points using new scoring system (see below) and exclusion of SGS, LDS, and vEDS.
    • With EL but without Ao, FBN1 mutation previously associated with Ao is required for diagnosis of MFS.
  • Systemic features, scoring system (see "Physical Exam " ):
    • Wrist and thumb sign +3 (thumb protrudes from clenched fist); wrist or thumb sign +1 (encircles wrist with little finger and thumb of opposite hand)
    • Pectus carinatum deformity +2; pectus excavatum or chest asymmetry +1
    • Hindfoot deformity +2; pes planus +1
    • Pneumothorax +2
    • Dural ectasia +2
    • Protrusio acetabuli +2 by x-ray, CT, or MRI
    • Reduced upper-to-lower segment ratio (US/LS) and increased arm/height and no severe scoliosis +1
    • Scoliosis or thoracolumbar kyphosis +1
    • Reduced elbow extension +1
    • Facial features ( ¢ … —;) +1
    • Skin striae +1
    • Myopia >3 diopters +1
    • Mitral valve prolapse (all types) +1
  • Maximum: 20 points; score ≥7 indicates systemic involvement.
  • Positive family history requires a family member independently diagnosed using above criteria.
  • With a positive family history, MFS can be diagnosed with ectopia lentis, or systemic score ≥7, or aortic root dilatation with Z ≥2 in persons >20 years old, or Z ≥3 in persons <20 years old.
  • In persons <20 years old who have negative family history and suggestive findings but who do not meet Ghent criteria, "nonspecific connective tissue disorder "  is diagnosed; close follow-up is recommended.
  • In the presence of a relevant FBN1 mutation, "potential MFS "  is diagnosed and close follow-up is recommended.
  • In adults who have suggestive findings but who do not meet Ghent criteria, consider alternative diagnoses: ectopia lentis syndrome, mitral valve prolapse syndrome, MASS (Mitral valve prolapse, Aortic dilation, Skin, and Skeletal) phenotype.

PHYSICAL EXAM


  • Facial features: dolichocephaly (head length longer than expected compared with width), enophthalmos, down-slanting palpebral fissures, malar hypoplasia, micrognathia
  • High-arched, narrow palate
  • Thumb sign: distal phalanx of thumb protrudes from clenched fist; wrist sign: thumb and 5th digit overlap when circling wrist.
  • Pectus carinatum deformity: pectus excavatum or chest asymmetry beyond normal variation
  • Hindfoot valgus with forefoot abduction and lowering of the midfoot; distinguish from pes planus
  • Height may be normal or may be ≥3.3 SD >mean.
  • Reduced upper segment-to-lower segment (US/LS) ratio: 0.93 in unaffected individuals versus ≤0.85 in affected white adults, ≤0.78 in affected black adults. US is measured from the top of the head to the top of the midpubic bone; LS from the top of the pubic bone to the sole of the foot. In children, abnormal US/LS: US/LS <1, age 0 to 5 years; US/LS <0.95, 6 to 7 years; US/LS <0.9, 8 to 9 years; <0.85, age ≥10 years.
  • Increased arm span to height ratio >1.05
  • Scoliosis or thoracolumbar kyphosis is diagnosed if, on bending forward, there is a vertical difference ≥1.5 cm between the ribs of the left and right hemithorax.
  • Reduced elbow extension if angle between upper and lower arm measures ≤170 degrees on full extension
  • Skin: Striae atrophicae are significant if not associated with significant weight changes (or pregnancy) and if located on midback, lumbar region, upper arm, axilla, or thigh.
  • Because of lack of specificity, joint hypermobility, high-arched palate, and recurrent or incisional herniae were removed from diagnostic criteria (1).

DIFFERENTIAL DIAGNOSIS


Clinical manifestations overlapping with MFS in cardiovascular, ocular, and skeletal systems: ‚  
  • Ectopia lentis syndrome: no aortic root dilatation
  • Mitral valve prolapse syndrome: MVP; limited systemic features may include pectus excavatum, scoliosis, mild arachnodactyly; aortic enlargement and ectopia lentis preclude this diagnosis.
  • MASS phenotype: mitral valve prolapse; myopia; borderline, nonprogressive aortic enlargement (Z <2); and nonspecific skeletal and skin involvement. Aortic involvement in MASS usually nonprogressive; some risk for more severe vascular involvement.
  • Shprintzen-Goldberg, Loeys-Dietz, Ehlers-Danlos, Stickler syndromes; congenital contractural arachnodactyly; Weill-Marchesani syndrome, multiple endocrine neoplasia type 2B, fragile X
  • Homocystinuria: Marfanoid habitus, thrombosis, mental retardation; urine amino acid analysis is diagnostic; lens dislocates downward.
  • Familial thoracic aortic aneurysm
  • Aortopathy NGS panel likely to play a more prominent role, especially as VUS are classified (3)

DIAGNOSTIC TESTS & INTERPRETATION


  • Sequencing of FBN1 is the preferred method for molecular diagnosis. Mutations can be found in 95% of patients meeting diagnostic criteria for MFS.
  • Specific criteria have been established (1) for FBN1 mutations causative of MFS. FBN1 mutation is a valuable marker for risk or aortic dissection (4).
  • Echocardiography: Measure aortic root at the level of sinuses of Valsalva; check for mitral valve prolapse. The Marfan Foundation has nomograms to calculate aortic root Z-score in children (http://www.marfan.org/).
  • In patients whose physical exam is suggestive of MFS, measure urinary homocystine to rule out homocystinuria, an inborn error of metabolism.
  • Anteroposterior (AP) radiograph: protrusio acetabuli
  • Scoliosis: Cobb angle ≥20 degrees on radiographs; imaging for MFS diagnosis or as per clinical exam
  • Hindfoot valgus with forefoot abduction and lowering of the midfoot: anterior and posterior views
  • MRI or CT to evaluate for dural ectasia and if symptomatic, symptoms highly variable, nonspecific, and include lower back pain

Diagnostic Procedures/Other
  • Ectopia lentis is diagnosed on slit-lamp examination after maximal dilatation of the pupil (60%); lens dislocation is most often upward and temporal.
  • Myopia: Common in the general population; myopia >3 diopters contributes to MFS systemic score.
  • Elongated globe, keratoconus, increased risk of vitreous or retinal detachment, glaucoma, and early cataract formation

Test Interpretation
  • Cystic medial necrosis of the aorta: descriptive, not pathognomonic
  • Myxomatous degeneration of cardiac valves

TREATMENT


MEDICATION


  • Prevention of aortic complications: Ž ²-adrenergic blockers. Dosage adjusted to target heart rate (resting rate 60 bpm, increase to ≤110 bpm after moderate exertion or <100 bpm after submaximal exercise) (1)[C]
  • If Ž ²-blockers contraindicated: Ca++ channel blockers, ACE inhibitors, and ARBs may retard aortic dilation in children and adolescents (5)[B].
  • Consider antibiotic prophylaxis for dental procedures in presence of mitral or aortic regurgitation (http://www.marfan.org/resource/fact-sheet/endocarditis-prophylaxis-people-marfan-syndrome#.VhMqKvlViko).
  • Recent studies support losartan plus Ž ²-blockers to prevent progressive aortic root dilatation (6)[B].

ISSUES FOR REFERRAL


Genetics, cardiology, orthopedics, ophthalmology ‚  

SURGERY/OTHER PROCEDURES


  • When cardiac symptoms develop or aortic root diameter is ≥5 cm, consider surgical intervention (7). Many MFS patients will ultimately require reconstructive cardiovascular surgery:
    • Dissection of ascending aorta (type A) is a surgical emergency. Consider prophylactic surgery when diameter of sinus of Valsalva approaches 5 cm, rate of change approaches 1 cm/year, and with progressive aortic regurgitation (3); other risk factors: family history, other cardiac pathology, pregnancy.
    • Dissection of descending thoracic aorta (type B): Surgical indications include intractable pain, limb or organ ischemia, and aortic diameter >5.5 cm (or rapidly increasing) (1).
  • Mitral valve repair: for severe mitral valve regurgitation or progressive LV dilatation or dysfunction, or in patients undergoing valve-sparing root replacement (1)
  • Lens subluxation: Incidence of glaucoma is high, so surgery is performed only if the condition cannot be treated with corrective lenses; surgical removal of lens for opacity, impending complete luxation, lens-induced glaucoma or uveitis, or anisometropia or refractive error not amenable to optical correction (1)
  • Severe pectus excavatum may interfere with pulmonary or cardiac function and require surgery.
  • Scoliosis: bracing for curves 20 to 40 degrees until growth is complete or surgery if >40 degrees
  • Surgery for only most severe cases of dural ectasia
  • Hip replacement in middle age or later if protrusio acetabuli has led to severe arthritic change

ONGOING CARE


FOLLOW-UP RECOMMENDATIONS


  • Avoid sports that can increase aortic root enlargement or pneumothorax; in general, avoid contact sports, Valsalva, breathing against resistance, and exhaustion (8)[C].
  • Exercise restrictions: Follow recommendation from the National Marfan Foundation (http://www.marfan.org/) and guidelines from the American Heart Association/American College of Cardiology Task Forces.

Patient Monitoring
Exams at least twice/year while patient is growing, with attention to the cardiovascular system and to scoliosis. ‚  
  • Cognitive ability is usually normal, but visual and medical difficulties may interfere with learning (8)[C].
  • Cardiac
    • Aortic root dilatation in MFS is usually progressive, warrants vigilance even when not seen on initial examination; age <20 years, yearly echocardiogram; adults with repeatedly normal aortic root measurements, echo every 2 to 3 years (1)[C].
    • Yearly echocardiograms (initially), more frequent if aortic diameter is increasing rapidly ( ≥5 cm/year) or is approaching surgical threshold ( ≥4.5 cm in adults)
    • Regular imaging after surgical repair of aorta
  • Musculoskeletal
    • Excessive linear growth of long bones, extremities disproportionately long, paucity of muscle mass, peak growth velocity 2 years early. Growth curves for MFS are available (8)[C].
    • Clinical evaluation for scoliosis earlier than in general population; plain radiographs of spine during growth years
    • Evaluate for scoliosis, joint laxity, and pectus deformity every visit to age 1 year, annually age 1 to 5 years, semiannually age 6 to 18 years, and yearly thereafter.
    • Bone age in preadolescence: Consider hormonal therapy if with large discrepancy (8)[C].
    • Scoliosis or pectus deformity may progress more rapidly than in those without MFS.
    • Excellent prognosis for scoliosis curves <30 degrees; bracing may be effective for curves <35 degrees; rapid progression likely if curve >50 degrees (8)[C]
  • Annual ophthalmologic evaluation: ectopia lentis, myopia, cataract, glaucoma, and retinal detachment; myopia is very common in MFS with early onset, rapid progression, and high degree of severity; early monitoring, aggressive refraction to prevent amblyopia (1)[C]
  • Respiratory: pulmonary function tests (PFTs) for pulmonary complaints; obstructive sleep apnea
  • Review diagnosis, examine family members, offer support group information at diagnosis and PRN.
  • Provide genetic counseling at diagnosis, discuss pregnancy risks in adolescence, discuss activity restrictions starting age 6 years, transition planning in early adolescence. Review symptoms of potential catastrophic events: aortic dissection, vision changes, and pneumothorax starting age 6 years.

PATIENT EDUCATION


  • National Marfan Foundation, http://www.marfan.org/
  • NLM Genetics Home Reference: Marfan syndrome http://ghr.nlm.nih.gov/condition/marfan-syndrome

PROGNOSIS


Life-threatening complications involve cardiovascular dysfunctions. In 1972, lifespan was 32 years. Currently, lifespan is nearly normal. ‚  

COMPLICATIONS


Bacterial endocarditis, aortic dissection, aortic or mitral valve insufficiency, dilated cardiomyopathy, retinal detachment, glaucoma, pneumothorax ‚  

REFERENCES


11 Loeys ‚  BL, Dietz ‚  HC, Braverman ‚  AC, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet.  2010;47(7):476 " “485.22 Faivre ‚  L, Collod-Beroud ‚  G, Callewaert ‚  B, et al. Pathogenic FBN1 mutations in 146 adults not meeting clinical diagnostic criteria for Marfan syndrome: further delineation of type 1 fibrillinopathies and focus on patients with an isolated major criterion. Am J Med Genet A.  2009;149A(5):854 " “860.33 Wooderchak-Donahue ‚  W, VanSant-Webb ‚  C, Tvrdik ‚  T, et al. Clinical utility of a next generation sequencing panel assay for Marfan and Marfan-like syndromes featuring aortopathy. Am J Med Genet A.  2015;167A(8):1747 " “1757.44 Faivre ‚  L, Collod-Beroud ‚  G, Child ‚  A, et al. Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands. J Med Genet.  2008;45(6):384 " “390.55 Williams ‚  A, Davies ‚  S, Stuart ‚  AG, et al. Medical treatment of Marfan syndrome: a time for change. Heart.  2008;94(4):414 " “421.66 Groenink ‚  M, den Hartog ‚  AW, Franken ‚  R, et al. Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. Eur Heart J.  2013;34(45):3491 " “3500.77 Benedetto ‚  U, Melina ‚  G, Takkenberg ‚  JJ, et al. Surgical management of aortic root disease in Marfan syndrome: a systematic review and meta-analysis. Heart.  2011;97(12):955 " “958.88 Tinkle ‚  BT, Saal ‚  HM. Health supervision for children with Marfan syndrome. Pediatrics.  2013;132(4):e1059 " “e1072.

CODES


ICD10


  • Q87.40 Marfan 's syndrome, unspecified
  • Q87.43 Marfan 's syndrome with skeletal manifestation
  • Q87.418 Marfan 's syndrome with other cardiovascular manifestations
  • Q87.42 Marfan 's syndrome with ocular manifestations
  • Q87.410 Marfan 's syndrome with aortic dilation

ICD9


759.82 Marfan syndrome ‚  

SNOMED


  • 19346006 Marfan 's syndrome (disorder)
  • 234035006 Marfan 's syndrome affecting skin (disorder)
  • 57201002 Marfanoid joint hypermobility syndrome (disorder)

CLINICAL PEARLS


  • Because many features of MFS appear in the general population, diagnostic criteria have been established. Molecular diagnostic testing for FBN1 mutations will play an increasing role.
  • Screen very tall athletes for aortic root dilatation.
  • Early diagnosis of homocystinuria is important because clinical complications can be minimized with appropriate diet and medication.
  • Ectopia lentis and aortic root dilatation are best discrimination features, but height ≥3.3 SD above the mean is a simple discriminant in primary care.
Copyright © 2016 - 2017
Doctor123.org | Disclaimer